经房间隔经导管三尖瓣瓣中瓣植入球囊扩张生物瓣。
Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis.
机构信息
Division of Cardiac Surgery, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
出版信息
Ann Thorac Surg. 2010 Nov;90(5):1696-7. doi: 10.1016/j.athoracsur.2010.04.101.
Transcatheter valve-in-valve implantation into failing mitral and aortic bioprosthetic valves have been reported. This strategy avoids performing high-risk repeat cardiac surgery in elderly patients with multiple comorbidities. Tricuspid valve-in-valve implantation has not been described. We report a case of failing bioprosthetic tricuspid valve in a 48-year-old woman with carcinoid syndrome. We attempted a transatrial transcatheter approach and we successfully deployed a 26-mm Edwards Sapien balloon expandable bioprosthesis (Edwards Lifesciences, Irvine, CA) into a severely stenotic tricuspid bioprosthesis. This case demonstrates the technical feasibility and safety of this approach. Therefore, tricuspid valve-in-valve implantation may be a viable treatment alternative in carefully selected patients.
经导管 valve-in-valve 植入术已应用于二尖瓣和主动脉生物瓣衰败的患者。这一策略避免了对患有多种合并症的老年高危患者进行重复心脏手术。三尖瓣 valve-in-valve 植入尚未见报道。我们报告了一例类癌综合征 48 岁女性生物瓣三尖瓣衰败患者。我们尝试经房间隔(transatrial)的经导管(transcatheter)方法，并成功地将 26 毫米 Edwards Sapien 球囊扩张生物瓣（爱德华生命科学公司，欧文，加利福尼亚州）植入严重狭窄的三尖瓣生物瓣。本病例证明了这种方法的技术可行性和安全性。因此，在仔细选择的患者中，三尖瓣 valve-in-valve 植入术可能是一种可行的治疗选择。
Zotero 插件